East Brunswick, New Jersey. — Hepatitis B Foundation, a national nonprofit organization dedicated to finding a cure and improving the quality of life for those affected by hepatitis B, is the newest partner of DiRx, a fast-growing digital pharmacy platform focused on generic medicine access and affordability. Hepatitis B is the most common serious liver infection in the world, and a 2021 study estimated that as many as 2.4 million people in the U.S. live with hepatitis B.
DiRx has added two front-line medications for chronic hepatitis B infection – generic Viread® (Tenofovir) and generic Baraclude® (Entecavir) – and will be offering the medications at greatly discounted prices. Specifically, 30-count supplies of Entecavir will be $33, and Tenofovir $21, compared to average retail price of $1,188.
To access Tenofovir or Entecavir at discounted prices, patients should visit DiRxHealth.com and use promo code HBFSAVE. Any hepatitis B patient with a valid U.S. prescription will be able to order and benefit from free U.S. shipping, with no pre-qualifications and health insurance required.
Known for their exceptional attention to improving the quality of life for those affected by hepatitis B worldwide through education and patient advocacy, as well as their focus on finding a cure through research, the Hepatitis B Foundation is a global leader in the field. The organization is recognized for making great strides for this mostly overlooked and underfunded disease.
“Pursuing our goals of enabling better access and affordability of generic prescription medicine for all Americans, we are delighted to partner with the Hepatitis B Foundation to help individuals living with hepatitis B benefit from significantly discounted prices for their much-needed therapies.” said Satish Srinivasan, Founder & CEO at DiRx Health. “The Hepatitis B Foundation acts as the primary source of information for patients and their families and has been a leader in funding focused research, promoting disease awareness, and supporting immunizations.”
” Access to proper health care for people living with hepatitis B is one of our highest priorities, and that includes helping to ensure they can afford their medications,” Chari Cohen, DrPH, MPH, senior vice president of the Hepatitis B Foundation, said. “DiRx will provide people living with hepatitis B in the U.S. with a new option for obtaining the medications they require, so we very much appreciate the company’s offer to partner with our organization.”
In addition to these critical medications for hepatitis B, DiRx carries more than 1,200 FDA-approved generic medicines with prices as low as $3 per month, including shipping. Ordering medicine from DiRx does not require any pre-approvals or insurance. To help more consumers access essential medications, for a limited time, a 1-month supply (up to $100 per order) is also available for free.
DiRx is an online pharmacy that delivers savings on commonly prescribed, FDA-approved generic medicines without the need for insurance. Founded by industry experts, DiRx draws a straight line from supply to demand to streamline the path between the manufacturer and the consumer. This lowers costs and makes more medicine accessible to more people. DiRx offers a viable model for businesses and community organizations while simplifying how consumers fill, pay for, and receive maintenance medicine. To learn more, visit DiRxHealth.com , or call 877-FOR-DIRX (877-367-3479). You can also find DiRx on socials: Facebook, Instagram, Twitter and LinkedIn.
Hepatitis B Foundation is the nation’s leading nonprofit organization solely dedicated to finding a cure for hepatitis B and improving the quality of life for those affected worldwide through research, education, and patient advocacy. Founded in 1991, the Hepatitis B Foundation is based in Doylestown, PA., with an office in Washington, D.C. To learn more, go to www.hepb.org and www.hepb30years.org , read our blog at hepb.org/blog , follow us on Twitter, Instagram and Facebook (@hepbfoundation) or call us at 215-489-4900. To donate, contact Jean Holmes at 215-489-4900 or email@example.com.